Definium Therapeutics, Inc. (DFTX)

Healthcare · Biotechnology · NASDAQ

Definium Therapeutics, Inc. (DFTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.42B and a free-cash-flow yield of -3.6%.

Market cap	$5.42B
Trailing P/E	—
FCF yield	-3.6%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live DFTX data on Nama Insights →